Medtronic’s PulseSelect Becomes First FDA-Approved PFA System
CardiacWire
DECEMBER 17, 2023
The AFib pulsed field ablation treatment era officially began in the US last week, following the FDA approval of Medtronic’s PulseSelect Pulsed Field Ablation System for the treatment of both paroxysmal and persistent atrial fibrillation. PFA systems use electroporation (short electrical pulses) to achieve pulmonary vein isolation. PFA is seen as safer and faster than current thermal ablation techniques, reducing damage to surrounding tissues and improving procedural efficiency.
Let's personalize your content